Nektar Therapeutics
NKTR
NKTR
194 hedge funds and large institutions have $2.28B invested in Nektar Therapeutics in 2016 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 66 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
23% less call options, than puts
Call options by funds: $4.47M | Put options by funds: $5.77M
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
194
Holding in Top 10
1
Calls
$4.47M
Puts
$5.77M
Top Buyers
| 1 | +$24.9M | |
| 2 | +$16.8M | |
| 3 | +$12.9M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$12.9M |
| 5 |
Two Sigma Investments
New York
|
+$11.8M |
Top Sellers
| 1 | -$28.8M | |
| 2 | -$18M | |
| 3 | -$17.2M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$14.3M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$13.6M |